The complex dynamics of the tumor-immune interaction during tumor progression have been characterized by integrating genomic and proteomic experiments. The Immunome, a reference compendium of markers for the majority of immune cell subpopulations was used to describe the immune landscape in cancer. The immune contexture is at the cornerstone in the success of cancer immunotherapies. Markers with the highest clinical relevance were summarized as the consensus immunoscore. This immune evaluation refines the prognosis of the patients and the chemotherapy decision-making process and was introduced as essential and desirable diagnostic criteria into three major international guidelines.
Keywords: T-cells; chemotherapy; colorectal cancer; immune landscape; immunity; immunoscore; immunotherapy; prognosis; survival; tumor microenvironment.
© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.